Elicio Therapeutics Inc.

NASDAQ: ELTX · Real-Time Price · USD
11.78
1.94 (19.72%)
At close: Aug 18, 2025, 3:59 PM
12.02
2.08%
After-hours: Aug 18, 2025, 07:21 PM EDT

Elicio Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-54.61M -51.28M -51.9M -46.84M -38.66M -38.99M -35.2M -32.9M -29.43M -29.18M -35.39M -13.85M -22.35M -32.13M -24.08M -67.84M -69.81M -73.08M
Depreciation & Amortization
1.15M 1.16M 1.18M 1.16M 1.14M 1.35M 1.17M 511.32K 532.32K 419.53K 537.53K 1.13M 1.06M 874K 698.3K 621.3K 545.3K 509.3K
Stock-Based Compensation
2.04M 1.66M 1.47M 1.31M 1.32M 1.28M 1.18M 1.04M 811.61K 645.61K 578.5K 464.59K 354.59K 241.59K 430.07K 345.38K 345.38K 345.38K
Other Working Capital
1.93M 3.44M 7.29M 1.07M 4.86M 2.61M 1.6M 2.28M -2.03M -813.35K -607.35K -28.12M -28.53M -26.75M -27.5M 32.91M 31.53M 28.63M
Other Non-Cash Items
11.57M 7.01M 8.21M 7.51M -1.56M 2.75M 1.23M 1.25M 2.23M 8.49M 9.91M 15.1M 18.16M 12.82M 11.83M 22.44M 27.7M 29.89M
Deferred Income Tax
16K 16K 16K n/a -16K -16K -16K 657.42K 1.02M 1.02M 1.02M 360K n/a n/a n/a n/a n/a n/a
Change in Working Capital
4.74M 6.37M 3.96M -1.35M 1.65M -2.14M -57K 376.74K -4.42M 1.46M 516.74K -29.65M -31.37M -30.05M -29.48M 35.32M 23.26M 22.1M
Operating Cash Flow
-35.09M -35.06M -37.07M -38.22M -36.13M -36.68M -32.69M -30.07M -30.28M -14.66M -22.18M -29.27M -39.08M -55.74M -46.16M -11.21M -17.95M -20.23M
Capital Expenditures
-45K -87K -87K -42K -87K -49K -66K -160.84K 443.16K -111.84K -603K -544.17K -1.16M -849.17K -416.85K -390.85K -330.85K -96.85K
Cash Acquisitions
n/a n/a n/a n/a n/a 34K 34K 34K 34K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
42K 42K 45K 45K 3K 10M n/a n/a n/a -10M n/a n/a n/a 4.12K n/a n/a n/a n/a
Investing Cash Flow
-45K -87K -84K -39K -84K -12K -32K -126.84K 477.16K -111.84K -598.88K -540.04K -1.16M -845.04K -416.85K -390.85K -330.85K -96.85K
Debt Repayment
n/a n/a n/a 29.73M 10M 13.27M 23.27M 13.27M 13.27M 10.01M 14K 307K 307K 293K 293K n/a 31.22M 32.12M
Common Stock Repurchased
n/a n/a n/a -150K n/a -150K -150K -233 -150.23K -233 -233 n/a n/a n/a n/a -36K -36K -36K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
30.71M 30.72M 36.69M 6.96M -14.02M 17.6M 11.68M 21.74M 31.68M 44.23K -9.77K -78K -109K -1.33M -1.15M -1.14M -1.05M 170.25K
Financial Cash Flow
53.24M 41.63M 42.32M 49.1M 18.4M 39.6M 38.61M 42.79M 51.51M 31.26M 21.2M 10.43M 2.35M -1.29M 3.84M 3.64M 34.16M 53.59M
Net Cash Flow
18.28M 6.53M 5.19M 10.83M -17.85M 2.91M 5.89M 12.59M 21.15M -62.7M -80.34M -98.13M -116.08M -44.3M -29.57M -15.59M -1.03M -1.03M
Free Cash Flow
-35.13M -35.15M -37.16M -38.26M -36.22M -36.73M -32.76M -30.23M -29.83M -14.78M -22.78M -29.81M -40.24M -56.59M -46.58M -11.6M -18.29M -20.32M